AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
A Study Evaluating the Efficacy of Administered Maintenance Treatments in Bipolar Disorder I and II.
Completed
- Conditions
- Bipolar Disorder
- First Posted Date
- 2010-09-16
- Last Posted Date
- 2011-12-20
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 294
- Registration Number
- NCT01202604
- Locations
- 🇬🇷
Research Site, Serres, Greece
An Epidemiological Study to Evaluate Standard Daily Practice in Managing Patients With Arterial Hypertension
Completed
- Conditions
- Hypertension
- First Posted Date
- 2010-09-15
- Last Posted Date
- 2012-01-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 300
- Registration Number
- NCT01201980
- Locations
- 🇷🇸
Research Site, Sremska Kamenica, Serbia
A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Painful Diabetic Polyneuropathy
- First Posted Date
- 2010-09-14
- Last Posted Date
- 2014-04-25
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 134
- Registration Number
- NCT01201317
- Locations
- 🇨🇦
Research Site, Laval, Canada
Helicobacter Pylori Eradication Treatment in Patients With Duodenal Ulcers
Completed
- Conditions
- Duodenal Ulcer
- First Posted Date
- 2010-09-13
- Last Posted Date
- 2013-11-25
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 59
- Registration Number
- NCT01199536
- Locations
- 🇷🇺
Research Site, Moscow, Russian Federation
A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Posttraumatic Neuralgia..
- First Posted Date
- 2010-09-13
- Last Posted Date
- 2014-04-25
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 133
- Registration Number
- NCT01200524
- Locations
- 🇬🇧
Research Site, Manchester, United Kingdom
The Study to Describe Symptom Control and Impact on Daily Life in Gastroesophageal Reflux Disease (GERD) Patients
Completed
- Conditions
- Gastroesophageal Reflux Disease
- First Posted Date
- 2010-09-13
- Last Posted Date
- 2012-04-17
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1233
- Registration Number
- NCT01200550
- Locations
- 🇧🇦
Research Site, Zivinice, Bosnia and Herzegovina
Study to Evaluate the Interaction Between Aspirin and Nexium
- First Posted Date
- 2010-09-10
- Last Posted Date
- 2010-11-19
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 34
- Registration Number
- NCT01199328
- Locations
- 🇺🇸
Research Site, Springfield, Missouri, United States
A Drug-Drug Interaction Study to Study the Effect of AZD1981 on Warfarin
- First Posted Date
- 2010-09-10
- Last Posted Date
- 2011-02-09
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 28
- Registration Number
- NCT01199341
- Locations
- 🇸🇪
Research Site, Uppsala, Sweden
A Study to Assess the Safety, Tolerability and Pharmacokinetics of Modified-Release Formulations of AZD1446 After Oral Single and Repeated Doses
- First Posted Date
- 2010-09-10
- Last Posted Date
- 2011-02-17
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 24
- Registration Number
- NCT01199315
- Locations
- 🇯🇵
Research Site, Fukuoka, Japan
Evaluation of the Drug-drug Interaction Between FosD and Verapamil When Taken Together in Healthy Volunteers
Phase 1
Completed
- Conditions
- Drug Drug InteractionsHealthy Volunteers
- Interventions
- Drug: FOSTAMATIN
- First Posted Date
- 2010-09-09
- Last Posted Date
- 2010-11-23
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 15
- Registration Number
- NCT01197781
- Locations
- 🇺🇸
Recruiting Site, Overland Park, Kansas, United States